Horizon Kinetics Medical ETF Rating $26.94 +0.19 (+0.71%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsRatingsTrends Horizon Kinetics Medical ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.MEDX Aggregate RatingModerate Buy 2.66Holdings in MEDX have an aggregate rating of Moderate Buy based on 422 analyst ratings issued in the past year covering 31 companies (87.4% of the portfolio).MEDX Aggregate Price Target$26.94High Prediction$26.94Average Prediction$26.94Low Prediction$26.94Holdings in MEDX have an aggregate price target of $26.94 and a range of $26.94 to $26.94 covering 31 companies (87.4% of the portfolio).MEDX Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy5 Buy rating(s)Moderate Buy17 Moderate Buy rating(s)Hold9 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Horizon Kinetics Medical ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 31 MEDX Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings16.06%LLYEli Lilly and Company$767.76+1.3%4.9956 of 5 stars2.81$1,002.22 30.5%21Gap UpHigh Trading Volume8.07%ABBVAbbVie$175.58+2.4%4.9359 of 5 stars2.88$205.70 17.2%24Analyst ForecastInsider TradeHigh Trading Volume6.17%BMYBristol-Myers Squibb$57.33+1.8%4.7878 of 5 stars2.25$55.64 -2.9%20High Trading Volume5.54%AMGNAmgen$263.38+0.8%4.4708 of 5 stars2.40$319.67 21.4%25Analyst DowngradeGap UpHigh Trading Volume5.01%AZNAstraZeneca$65.35+1.4%4.0441 of 5 stars2.91$89.75 37.3%114.56%JNJJohnson & Johnson$144.47+0.6%4.8925 of 5 stars2.50$174.73 20.9%14High Trading Volume4.37%ALNYAlnylam Pharmaceuticals$245.44+2.8%4.4124 of 5 stars2.71$298.09 21.5%24Analyst Upgrade4.21%ALKSAlkermes$29.71-0.9%4.6624 of 5 stars2.58$35.42 19.2%12Positive NewsHigh Trading Volume4.06%MRKMerck & Co., Inc.$98.05-1.5%4.9889 of 5 stars2.71$127.13 29.7%21Analyst DowngradeHigh Trading Volume3.96%PFEPfizer$26.36+2.3%4.9838 of 5 stars2.47$32.14 21.9%17Analyst ForecastOptions VolumeAnalyst RevisionHigh Trading Volume3.35%REGNRegeneron Pharmaceuticals$701.85-0.9%4.6582 of 5 stars2.70$1,052.90 50.0%23Analyst ForecastHigh Trading Volume3.07%CRSPCRISPR Therapeutics$40.72+0.8%2.5041 of 5 stars2.44$77.93 91.4%18Analyst ForecastHigh Trading Volume2.92%BIIBBiogen$146.47-0.6%4.6302 of 5 stars2.45$242.68 65.7%29Analyst DowngradeHigh Trading Volume2.85%IONSIonis Pharmaceuticals$35.63+0.1%4.4165 of 5 stars2.68$60.65 70.2%19Analyst ForecastShort Interest ↓Analyst RevisionNews CoveragePositive NewsHigh Trading Volume2.37%GSKGSK$33.60+0.5%4.0825 of 5 stars2.60$43.25 28.7%10Analyst Downgrade1.80%BCYCBicycle Therapeutics$14.68-2.1%3.6057 of 5 stars2.78$35.25 140.1%9Analyst ForecastInsider TradeAnalyst RevisionNews Coverage1.73%BEAMBeam Therapeutics$29.01+8.0%3.4247 of 5 stars2.82$47.67 64.3%11High Trading Volume1.27%NTLAIntellia Therapeutics$12.18+0.8%4.1284 of 5 stars2.72$54.94 351.0%18High Trading Volume1.11%REPLReplimune Group$12.49+4.0%4.5404 of 5 stars3.13$17.29 38.4%8Insider TradeHigh Trading Volume0.81%HLNHaleon$9.69-0.1%3.3486 of 5 stars3.00$10.95 13.0%6Positive News0.71%VNDAVanda Pharmaceuticals$4.78+3.2%3.9318 of 5 stars3.00$15.50 224.3%2Analyst ForecastNews Coverage0.69%LTRNLantern Pharma$3.14-2.2%N/A2.001Gap Down0.62%GALTGalectin Therapeutics$1.04-48.0%1.9713 of 5 stars3.00$11.00 957.7%1News CoverageGap DownHigh Trading Volume0.47%GEHCGE HealthCare Technologies$78.91+1.9%3.6265 of 5 stars2.64$95.46 21.0%14High Trading Volume0.41%TSVT2seventy bio$3.14+7.5%2.2166 of 5 stars2.56$9.00 186.6%9Positive News0.40%EDITEditas Medicine$1.31-2.2%4.3865 of 5 stars2.07$7.00 434.4%14High Trading Volume0.27%VTRSViatris$12.52+3.2%2.0581 of 5 stars2.00$13.67 9.2%3News CoverageHigh Trading Volume0.25%ALLOAllogene Therapeutics$1.87+1.6%2.8451 of 5 stars2.75$9.73 420.5%12Gap DownHigh Trading Volume0.16%PACBPacific Biosciences of California$1.97+2.1%1.5546 of 5 stars2.50$2.95 50.0%120.09%BLUEbluebird bio$8.50-7.9%2.4963 of 5 stars2.00$49.14 478.2%10Analyst ForecastHigh Trading Volume0.05%MURAMural Oncology$3.18+1.3%3.0909 of 5 stars3.25$16.00 403.1%4 This page (NASDAQ:MEDX) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Horizon Kinetics Medical ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Horizon Kinetics Medical ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MEDX Stock Alerts